Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (651-660 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|December 18, 2014
The level of HER2 expression is a predictor of antibody-HER2 trafficking behavior in cancer cellsSripad Ram, Dongyoung Kim, Raimund J Ober, et al.
Mabs|December 18, 2014
Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokineticsRyutaro Asano, Ippei Shimomura, Shota Konno, et al.
Mabs|December 18, 2014
Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonistThilipan Thaventhiran, Naif Alhumeed, Han X A Yeang, et al.
Mabs|December 18, 2014
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4Nathalie Kersual, Véronique Garambois, Thierry Chardès, et al.
Mabs|December 18, 2014
Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymeraseKanyarat Thueng-in, Jeeraphong Thanongsaksrikul, Surasak Jittavisutthikul, et al.
Mabs|December 18, 2014
Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibodyYosdel Soto, Niurka Mesa, Yumisley Alfonso, et al.
Mabs|December 18, 2014
Effect of formulation on the stability and aerosol performance of a nebulized antibodyRenaud Respaud, Denis Marchand, Christelle Parent, et al.
Mabs|August 15, 2017
A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteinsWeichen Xu, Rod Brian Jimenez, Rachel Mowery, et al.
Mabs|August 17, 2017
IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody developmentDanlin Yang, Rachel Kroe-Barrett, Sanjaya Singh, et al.
Mabs|August 29, 2017
Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomicsAdam S Adler, Rena A Mizrahi, Matthew J Spindler, et al.
Pageof 184

Showing results (651-660 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|December 18, 2014
The level of HER2 expression is a predictor of antibody-HER2 trafficking behavior in cancer cellsSripad Ram, Dongyoung Kim, Raimund J Ober, et al.
Mabs|December 18, 2014
Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokineticsRyutaro Asano, Ippei Shimomura, Shota Konno, et al.
Mabs|December 18, 2014
Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonistThilipan Thaventhiran, Naif Alhumeed, Han X A Yeang, et al.
Mabs|December 18, 2014
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4Nathalie Kersual, Véronique Garambois, Thierry Chardès, et al.
Mabs|December 18, 2014
Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymeraseKanyarat Thueng-in, Jeeraphong Thanongsaksrikul, Surasak Jittavisutthikul, et al.
Mabs|December 18, 2014
Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibodyYosdel Soto, Niurka Mesa, Yumisley Alfonso, et al.
Mabs|December 18, 2014
Effect of formulation on the stability and aerosol performance of a nebulized antibodyRenaud Respaud, Denis Marchand, Christelle Parent, et al.
Mabs|August 15, 2017
A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteinsWeichen Xu, Rod Brian Jimenez, Rachel Mowery, et al.
Mabs|August 17, 2017
IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody developmentDanlin Yang, Rachel Kroe-Barrett, Sanjaya Singh, et al.
Mabs|August 29, 2017
Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomicsAdam S Adler, Rena A Mizrahi, Matthew J Spindler, et al.
Pageof 184